Enovis Corp. (ENOV)
27.68
+0.04
(+0.14%)
USD |
NYSE |
Nov 13, 16:00
27.65
-0.03
(-0.11%)
Pre-Market: 19:59
Enovis Enterprise Value : 2.929B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 2.929B |
| November 12, 2026 | 2.927B |
| November 11, 2026 | 2.979B |
| November 10, 2026 | 2.960B |
| November 09, 2026 | 2.978B |
| November 06, 2026 | 2.899B |
| November 05, 2026 | 2.983B |
| November 04, 2026 | 2.741B |
| November 03, 2026 | 2.537B |
| November 02, 2026 | 2.521B |
| October 30, 2026 | 2.481B |
| October 29, 2026 | 2.648B |
| October 28, 2026 | 2.596B |
| October 27, 2026 | 2.575B |
| October 26, 2026 | 2.553B |
| October 23, 2026 | 2.548B |
| October 22, 2026 | 2.577B |
| October 21, 2026 | 2.532B |
| October 20, 2026 | 2.526B |
| October 19, 2026 | 2.478B |
| October 16, 2026 | 2.462B |
| October 15, 2026 | 2.448B |
| October 14, 2026 | 2.403B |
| October 13, 2026 | 2.427B |
| October 12, 2026 | 2.385B |
| Date | Value |
|---|---|
| October 09, 2026 | 2.352B |
| October 08, 2026 | 2.337B |
| October 07, 2026 | 2.348B |
| October 06, 2026 | 2.382B |
| October 05, 2026 | 2.410B |
| October 02, 2026 | 2.357B |
| October 01, 2026 | 2.373B |
| September 30, 2026 | 2.386B |
| September 29, 2026 | 2.423B |
| September 28, 2026 | 2.406B |
| September 25, 2026 | 2.423B |
| September 24, 2026 | 2.412B |
| September 23, 2026 | 2.410B |
| September 22, 2026 | 2.419B |
| September 21, 2026 | 2.399B |
| September 18, 2026 | 2.399B |
| September 17, 2026 | 2.385B |
| September 16, 2026 | 2.435B |
| September 15, 2026 | 2.393B |
| September 14, 2026 | 2.409B |
| September 11, 2026 | 2.470B |
| September 10, 2026 | 2.420B |
| September 09, 2026 | 2.456B |
| September 08, 2026 | 2.511B |
| September 04, 2026 | 2.429B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Edwards Lifesciences Corp. | 57.83B |
| Intuitive Surgical, Inc. | 149.81B |
| Kewaunee Scientific Corp. | 150.78M |
| STAAR Surgical Co. | 1.152B |
| Stryker Corp. | 130.04B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.223M |
| Revenue (Quarterly) | 558.72M |
| Total Expenses (Quarterly) | 557.78M |
| EPS Diluted (Quarterly) | 0.0537 |
| Gross Profit Margin (Quarterly) | 53.08% |
| Profit Margin (Quarterly) | 0.22% |
| Earnings Yield | -33.21% |
| Operating Earnings Yield | 5.69% |
| Normalized Earnings Yield | -8.224 |